10% Discount on Manual & Electric Hospital Beds - Starting from 3 July!

MediGear Ltd

GE SenoClaire 3D breast Tomosynthesis

  1. Home
  2. Shop
  3. Medical Diagnostic Equipment
  4. GE SenoClaire 3D breast Tomosynthesis
✓ Certified Professional Seller GE SenoClaire 3D breast Tomosynthesis
GE SenoClaire 3D breast Tomosynthesis
GE HealthCare Medical Diagnostic Equipment

GE SenoClaire 3D breast Tomosynthesis

3D Breast Imaging with Clarity, Confidence, and GE Innovation.

The GE SenoClaire is a 3D breast tomosynthesis system for hospital breast imaging centres, screening programmes, women's health clinics, dense breast services, and refurbished mammography procurement. With step-and-shoot tube motion, 9 low-dose exposures, ASiRDBT reconstruction, anti-scatter 3D grid, dual Mo/Rh focal spots, and same dose as 2D FFDM, the GE SenoClaire supports breast cancer screening. Available at Medigear.uk.

Sections
Mammography Unit
Categories
Medical Diagnostic Equipment
Condition
Good
Seller Type
Certified Professional Seller
CE & ISO Certified
Global Shipping
Supplier: Medigear
Share: Facebook LinkedIn Twitter Pinterest

The GE SenoClaire is a 3D digital breast tomosynthesis (DBT) system from GE Healthcare, engineered for hospital breast imaging centres, dedicated screening programmes, women's health clinics, dense breast imaging services, biopsy services, and refurbished mammography procurement. As the first FDA-approved digital breast tomosynthesis system to deliver the same low dose as a 2D full field digital mammography (FFDM) exam, the SenoClaire combines advanced 3D imaging with patient dose safety supporting confident screening worldwide today.

The defining SenoClaire capability is the step-and-shoot tube motion combined with 9 low-dose exposures over a 25° angular sweep. The tube makes a complete stop for each of the 9 exposures to preserve microcalcification sharpness and avoid image blur — distinct from continuous tube motion approaches. Combined with the dual-channel Mo/Rh X-ray tube providing optimal X-ray spectra based on breast density and compressed thickness, and the large Revolution Flat Panel Digital CMOS detector with high DQE at low dose and no pixel binning, the SenoClaire delivers excellent image quality.

The ASiRDBT iterative reconstruction algorithm is the SenoClaire image processing innovation. Unlike traditional filtered back-projection (FBP) algorithms, ASiRDBT produces images that closely resemble FFDM, significantly enhancing off-plane images by minimizing both in-plane and out-of-plane artifacts. The algorithm improves visibility of microcalcifications, maximizes detail preservation, and minimizes noise. Combined with the SenoClaire 3D anti-scatter grid — the first anti-scatter solution designed for tomosynthesis — the SenoClaire reduces scattered radiation supporting excellent image quality for thick breasts.

The SenoClaire integrates with the GE Senographe platform supporting upgradeability — compatible with Senographe Essential and Senographe Care, expandable to stereotaxy and SenoBright spectral mammography. V-Preview 2D synthesized images generated by GE Seno Iris software support the 3D CC/MLO + V-Preview CC/MLO screening protocol. IDI MammoWorkstation, dedicated 2D/3D hanging protocols, PACS compatibility, and ergonomic radiologist tools support practical integration across breast imaging today.

Step-and-Shoot Tube Motion

Step-and-shoot tube motion preserves microcalcification sharpness and avoids image blur. The tube makes a complete stop for each of the 9 low-dose exposures — distinct from continuous tube motion — supporting higher maximum contrast today.

9 Low-Dose Exposures Over 25° Sweep

The SenoClaire acquires 9 low-dose exposures over a 25° angular sweep around the compressed breast. The optimized angular range and exposure count balance image quality and dose, supporting effective tissue separation today.

Same Dose as 2D FFDM

The SenoClaire is the first FDA-approved digital breast tomosynthesis system to deliver the same low dose as a 2D full field digital mammography exam. The dose-equal-to-2D performance supports tomosynthesis screening adoption without dose escalation today.

ASiRDBT Iterative Reconstruction

The ASiRDBT iterative reconstruction algorithm produces images closely resembling FFDM. The algorithm minimizes both in-plane and out-of-plane artifacts compared to traditional FBP and improves microcalcification visibility across breast imaging services today.

Anti-Scatter SenoClaire 3D Grid

The SenoClaire 3D grid is the first anti-scatter solution designed for tomosynthesis. The grid reduces scattered radiation and improves detectability in 3D imaging, particularly for thick breasts, while maintaining dose efficiency across services today.

Dual-Channel Mo/Rh X-Ray Tube

The dual-channel X-ray tube provides Molybdenum and Rhodium spectra for optimal X-ray penetration based on breast density and compressed breast thickness. The dual spectra support image quality across diverse patient profiles today.

V-Preview Synthesized 2D Imaging

V-Preview 2D synthesized images generated by GE Seno Iris software from DBT images support the 3D CC/MLO + V-Preview CC/MLO screening protocol. The synthesized 2D supports radiologist workflow without additional dose today.

Breast Cancer Screening with Tomosynthesis

The GE SenoClaire anchors breast cancer screening with tomosynthesis across hospital breast imaging centres, dedicated screening programmes, and population-based programmes. Step-and-shoot motion, 9 low-dose exposures, ASiRDBT reconstruction, V-Preview synthesized 2D, and dose equal to 2D FFDM support effective screening across hospital and mobile screening services worldwide today during routine practice in busy screening programmes.

Dense Breast Imaging

Dense breast imaging benefits substantially from the SenoClaire 3D tomosynthesis approach that separates tissues and reduces structure overlap — a limiting factor in standard 2D mammography. The anti-scatter 3D grid and dual-channel Mo/Rh tube support imaging dense breasts above average thickness with reliable contrast across hospital breast imaging services worldwide today during routine practice.

Architectural Distortion and Mass Detection

Architectural distortion and mass detection benefit substantially from the SenoClaire tomosynthesis acquisition with superior sensitivity for architectural distortions and masses. Combined with ASiRDBT reconstruction and high-DQE detector imaging, the platform supports confident detection of subtle architectural distortion, irregular masses, and early breast cancers across hospital breast imaging services worldwide today.

Microcalcification Visualisation

Microcalcification visualisation benefits substantially from the SenoClaire's step-and-shoot tube motion that preserves microcalcification sharpness. Combined with high-DQE detector with no pixel binning, ASiRDBT iterative reconstruction, and dual-channel Mo/Rh tube, the platform supports detection of subtle microcalcification clusters across hospital breast imaging and cancer screening services worldwide today.

Diagnostic Workup and Biopsy Planning

Diagnostic workup and biopsy planning benefit from the SenoClaire's 3D tissue separation, ASiRDBT reconstruction, and Senographe platform upgradeability supporting stereotaxy and SenoBright contrast-enhanced spectral mammography. The combination supports detail review of suspicious findings, biopsy target verification, and diagnostic referrals across hospital breast imaging services worldwide today.

For Hospital Breast Imaging Centres

The GE SenoClaire brings 3D tomosynthesis to hospital breast imaging centres, dedicated screening programmes, and women's health clinics through step-and-shoot tube motion, 9 low-dose exposures, ASiRDBT iterative reconstruction, anti-scatter SenoClaire 3D grid, dual-channel Mo/Rh tube, V-Preview synthesized 2D, and same dose as 2D FFDM. Reliable GE Healthcare engineering, Senographe platform upgradeability, PACS compatibility, IDI MammoWorkstation, and proven service support meet stringent procurement compliance across institutional breast imaging services worldwide today during routine practice in busy daily settings.

For Screening Programmes and Upgrade Adoption

The SenoClaire supports screening programmes, tomosynthesis adoption, Senographe Essential and Senographe Care upgrade paths, ambulatory women's health clinics, and breast cancer screening expansion through its dose-equal-to-2D performance, upgrade compatibility, and ASiRDBT iterative reconstruction. Reliable GE Healthcare engineering and broad clinical applicability support practical integration across community screening services, screening programme expansions, and tomosynthesis adoption pathways worldwide today during clinical workflows.

For Medical Equipment Distributors

GE Healthcare is the globally established mammography manufacturer with strong brand recognition, comprehensive training resources, expert technical support, and reliable after-sales service networks worldwide. Distributors partnering with Medigear.uk gain access to a complete SenoClaire ecosystem supported by detailed documentation, warranty coverage, parts availability, and refurbished inventory. Sustained SenoClaire demand drives consistent distribution value across breast imaging, screening, and tomosynthesis channels worldwide today.

The GE SenoClaire 3D breast tomosynthesis is a clinically proven digital breast tomosynthesis platform combining step-and-shoot tube motion that preserves microcalcification sharpness with the tube making a complete stop for each of the 9 low-dose exposures over a 25° angular sweep, ASiRDBT iterative reconstruction algorithm that minimizes in-plane and out-of-plane artifacts and produces images closely resembling FFDM, anti-scatter SenoClaire 3D grid as the first anti-scatter solution designed for tomosynthesis, dual-channel Mo/Rh X-ray tube providing optimal spectra based on breast density, large Revolution Flat Panel Digital CMOS detector with high DQE at low dose, status as the first FDA-approved DBT to deliver the same low dose as a 2D FFDM exam, V-Preview 2D synthesized images for screening protocol, Senographe platform upgradeability supporting stereotaxy and SenoBright, and IDI MammoWorkstation integration in one GE Healthcare platform. Whether for screening or diagnostic workup, the SenoClaire delivers. Contact Medigear.uk for the SenoClaire today.

FAQ

Frequently Asked Questions

Everything buyers need to know about sourcing medical equipment through MediGear.

The GE SenoClaire is a 3D digital breast tomosynthesis system used for breast cancer screening with tomosynthesis, dense breast imaging, architectural distortion and mass detection, microcalcification visualisation, and diagnostic workup and biopsy planning. It serves hospital breast imaging centres, dedicated screening programmes, women's health clinics, dense breast imaging services, and refurbished mammography procurement worldwide today.

Digital breast tomosynthesis (DBT) is a 3D imaging technique that uses a short X-ray sweep around the compressed breast to acquire multiple low-dose exposures. The technique separates tissues and reduces overlapping structures — a limiting factor in standard 2D mammography. DBT improves visualisation of architectural distortions, masses, and microcalcifications across screening services worldwide today.

Step-and-shoot tube motion is a defining SenoClaire feature where the X-ray tube makes a complete stop for each of the 9 low-dose exposures. The tube stop preserves microcalcification sharpness and avoids image blur — distinct from continuous tube motion approaches. Step-and-shoot achieves higher maximum contrast for microcalcifications across breast imaging services worldwide today.

The SenoClaire acquires 9 low-dose exposures over a 25° angular sweep around the compressed breast. The optimized angular range and exposure count balance image quality and patient dose, supporting effective tissue separation and reduced structure overlap across hospital breast imaging and screening services worldwide today during routine clinical practice.

The GE SenoClaire is the first FDA-approved digital breast tomosynthesis system to deliver the same low dose as a 2D full field digital mammography (FFDM) exam. The dose-equal-to-2D performance supports tomosynthesis screening adoption without dose escalation, addressing patient dose concerns across screening programmes worldwide today during routine practice.

ASiRDBT is the SenoClaire iterative reconstruction algorithm for calcification artifact correction. Unlike traditional filtered back-projection (FBP), ASiRDBT produces images closely resembling FFDM, significantly enhancing off-plane images by minimizing in-plane and out-of-plane artifacts. The algorithm improves microcalcification visibility and supports diagnostic confidence across breast imaging today.

The SenoClaire 3D grid is the first anti-scatter solution designed for digital breast tomosynthesis. The grid reduces scattered radiation and improves detectability in 3D imaging, particularly for thick breasts above average thickness, while maintaining dose efficiency. The grid is a key innovation supporting reliable contrast across patient profiles worldwide today.

V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from SenoClaire DBT images. The 3D CC/MLO + V-Preview CC/MLO screening protocol supports tomosynthesis screening with synthesized 2D for radiologist workflow without additional radiation dose across hospital breast imaging and screening services worldwide today during routine practice.

Yes. The SenoClaire is designed for Senographe platform upgradeability and is fully compatible with Senographe Essential and Senographe Care installations. The Senographe platform supports SenoClaire 3D tomosynthesis, stereotaxy, and SenoBright contrast-enhanced spectral mammography as upgrades, protecting capital investment across services worldwide today.

The SenoClaire features a dual-channel X-ray tube providing Molybdenum (Mo) and Rhodium (Rh) spectra. The dual spectra support optimal X-ray penetration based on breast density and compressed breast thickness. Combined with dual 0.1 mm and 0.3 mm Rhodium spectrum focal spots and the GE Apollon tube, the platform supports diverse patient imaging worldwide today.

Medigear.uk supports site planning, installation, commissioning, and clinician training for the GE SenoClaire. Training covers digital breast tomosynthesis technique, step-and-shoot tube operation, ASiRDBT reconstruction, V-Preview synthesized 2D workflow, IDI MammoWorkstation use, PACS integration, and routine maintenance via authorised GE Healthcare service partners worldwide today during routine practice.

Yes. Medigear.uk supports certified refurbished GE SenoClaire procurement at cost-effective prices. Refurbished tomosynthesis systems undergo comprehensive inspection, detector verification, X-ray tube assessment, ASiRDBT calibration, anti-scatter grid checks, image quality verification, and quality control, providing a budget-friendly option for hospital breast imaging, screening programme, and mammography procurement worldwide today.